Takeshita Y, Honda M, Harada K, Kita Y, et al. Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial. Diabetes Care 2022 Jul 27. pii: 147324. doi: 10.2337/dc21-2049.
PMID: 35894933